Agreed. Also, only a company which has belief in its drugs would put so much into it as today’s Ann shows by appointing a head of manufacturing and engaging 2 world leading manufacturing companies. Please don’t underestimate how much public and media attention is on Relyvrio’s withdrawal and the void created again for ALS patients. I think the company is striking while the iron is hot and thru a structured and controlled approach because FDA isn’t going to approve anything in a hurry in the near term as it will be a big embarrassment. So moving ahead with speed to capitalise on the tailwinds but in a systematic and scientific manner is the right thing to do. AIMO.
Agreed. Also, only a company which has belief in its drugs would...
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.0¢ |
Change
-0.010(5.56%) |
Mkt cap ! $67.30M | |||
| Open | High | Low | Value | Volume |
| 17.5¢ | 18.0¢ | 16.3¢ | $581.7K | 3.408M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 502428 | 17.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.5¢ | 40529 | 1 |
View Market Depth
| Last trade - 16.10pm 10/05/2024 (20 minute delay) ? |
|
|||||
|
Last
17.5¢ |
Change
-0.010 ( 3.15 %) |
||||
| Open | High | Low | Volume | ||
| 17.5¢ | 18.0¢ | 16.0¢ | 3492891 | ||
| Last updated 15.59pm 10/05/2024 ? | |||||
| PAA (ASX) Chart |